INSTITUTIONAL RESEARCH

The best way to understand Hedgeye is to experience our analysts' work.

Hedgeye typically distributes research on a subscription basis, allowing broader access to notes, calls, and Black Books. The purchase price for individual sector research items below may be applied to new subscriptions within the quarter.

Get the research today!

Subscribe
SHOWING CANNABIS RESEARCH
RESTAURANT INSIGHTS | VOLATILE WEEK, CRON (-), TCNNF (+), VRNOF (-) Learn More
Buy Now

VOLATILE WEEK TCNNF (+), VRNOF (-)

Cannabis Insight | VP Sparks Hope, Big Week For Germany, The High Cost Of Banking Learn More
Buy Now

Is Vice President Kamala Harris's office actively engaging on cannabis policy issues?

Cannabis Unbound: Exploring the Benefits, Risks, and Realities of Legalization Learn More
Buy Now

Long Road Ahead for Cannabis Despite Potential Rescheduling Move

Cannabis Insight | Connecticut Needs Interstate Commerce & Maryland Residency Issues & The DCC Learn More
Buy Now

The need for Federal Legalization and Interstate commerce grows daily, as MD and CT are two great examples.

Cannabis Insight | The Battle for Florida and Germany Learn More
Buy Now

The Battle for Florida; is Germany finally ready;

Cannabis Insight | Opposition to rescheduling was inevitable, Deeper Look at PA, Cresco Learn More
Buy Now

The arguments for not rescheduling are weak and I Like PA to go Rec

Cannabis Insight | Oregon Lawsuit (Interstate Commerce) and Shifting Tides On Cannabis Support Learn More
Buy Now

Are "big things coming" on Interstate Commerce?

Cannabis Insight | COURTROOM CANNABIS CLASH & The Commerce Clause Is Undefeated Learn More
Buy Now

The DOJ argues for the dismissal of Boise, citing the rescheduling of cannabis. Many observers believe the case will likely face defeat.

From Reefer Madness to Federal Freedom: Is Marijuana Rescheduling on the Horizon? Learn More
Buy Now

Are we seeing the end of Federal Prohibition of Cannabis - Subscribe to get all the latest on the Cannabis Industry.

Cannabis Insight | Top 10 Reasons (TLRY), CA Cannabis in '24, GRWG (-) Learn More
Buy Now

Subscribe to Hedgeye Cannabis for daily insights into industry trends.

There's a better way to invest. Get our team of 40+ analysts working for you!
Contact Us
You're Leaving Hedgeye Risk Management...

By selecting this link, you are now leaving the Hedgeye Risk Management (“HRM”) website. The following website contains information concerning investment products managed by Hedgeye Asset Management (“HAM”), an affiliate of HRM, or a firm partnering with HAM, and is subject to HAM’s Privacy Policy. As a separate legal entity, all HAM asset management services are made independently by portfolio managers at HAM and, as such, funds may vary from HRM research.

HRM is not responsible for the accuracy or completeness of information on external websites. HRM does not make any representation regarding the advisability of investing in any investment product or any particular investment advisory. Any opinions or recommendations from linked websites are solely those of our affiliate and are not the opinions or recommendations of HRM.

HRM DOES NOT PROVIDE PERSONALIZED INVESTMENT ADVICE OR ENGAGE IN ANY ASSET MANAGEMENT SERVICE. LASTLY, THIS LINK IS NOT AN OFFER TO BUY OR A SOLICITATION TO SELL ANY SECURITY OR INVESTMENT PRODUCT, OR THE SOLICITATION OF ANY ADVISORY SERVICES.